JAVIER
GANDASEGUI ARAHUETES
Investigador en el periodo 2020-2021
Instituto de Salud Global de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Global de Barcelona (6)
2022
-
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
Gates Open Research, Vol. 6
-
Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control
The Lancet Infectious Diseases, Vol. 22, Núm. 11, pp. e341-e347
2020
-
Fasciola hepatica and Fasciola gigantica coexistence in domestic ruminants in Nigeria: application of a PCR-based tool
Tropical Animal Health and Production, Vol. 52, Núm. 6, pp. 3893-3897
-
Role of DNA-detection–based tools for monitoring the soil-transmitted helminth treatment response in drug-efficacy trials
PLoS Neglected Tropical Diseases, Vol. 14, Núm. 2
-
Teladorsagia circumcincta beta tubulin: the presence of the E198L polymorphism on its own is associated with benzimidazole resistance
Parasites & vectors, Vol. 13, Núm. 1, pp. 453
-
Zoonotic implications of onchocerca species on human health
Pathogens, Vol. 9, Núm. 9, pp. 1-17